4
Changes in Ownership
Larimar Therapeutics, Inc. Filed Acc 0001062993-22-019646
Chief Financial Officer bought 31,746 shares at $3.15 ($100,000)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Celano Michael Chief Financial Officer | 2022-09-16 | Purchase | +31,746 | $3.15 | $100,000 | 31,746 | D |
| Open-market purchases · 31,746 sh · avg $3.15 · $100,000 | |||||||
Loading xslF345X03/form4.xml…